Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor γ agonists

Chia Hui Lin, Yi Hui Peng, Mohane Selvaraj Coumar, Santhosh Kumar Chittimalla, Chun Chen Liao, Ping Chiang Lyn, Chin Chieh Huang, Tzu Wen Lien, Wen Hsing Lin, John T.A. Hsu, Jai Hong Cheng, Xin Chen, Jian Sung Wu, Yu Sheng Chao, Hwei Jen Lee, Chiun Gung Juo, Su Ying Wu, Hsing Pang Hsieh

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Abstract

Utilizing medicinal chemistry design strategies such as benzo splitting and ring expansion, we converted PPARα/γ dual agonist 1 to selective PPARα agonists 19 and 20. Compounds 19 and 20 were 2- to 4-fold better than rosiglitazone at PPARγ receptor, with 80- to 100-fold PPARγ selectivity over PPARα receptor. X-ray cocrystal studies in PPARγ and modeling studies in PPARα give molecular insights for the improved PPARγ potency and selectivity for 19 when compared to 1.

Original languageEnglish
Pages (from-to)2618-2622
Number of pages5
JournalJournal of Medicinal Chemistry
Volume52
Issue number8
DOIs
Publication statusPublished - 2009 Apr 23

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor γ agonists'. Together they form a unique fingerprint.

Cite this